Mikael L-Å Karlberg1, Måns Magnusson. 1. Department of Oto-Rhino-Laryngology, Head & Neck Surgery, Skåne University Hospital - Lund, Lund University, Lund, Sweden. mikael.karlberg@skane.se
Abstract
OBJECTIVE: To report the effects of glucocorticoid treatment of acute vestibular neuronitis on recovery of vestibular function and length of hospital stay. STUDY DESIGN: Prospective, consecutive case series compared with historic controls. SETTING: Secondary referral academic hospital. PATIENTS: Patients with acute vestibular neuronitis. One group treated with glucocorticoids within 3 days after symptom onset (n = 33) and 2 historic untreated control groups (n = 41 and n = 67). INTERVENTIONS: Oral prednisolone 50 mg/d for 5 days with tapering of doses for the next 5 days, alternatively with intravenous betamethasone 8 mg on the first 1 to 2 days if nauseated. MAIN OUTCOME MEASURES: Extent of unilateral vestibular paresis (%) in the caloric test at presentation and at 12 months of follow-up. Length of hospital stay (days). RESULTS: The initial vestibular paresis value did not differ between the treatment group and the control group. At follow-up, the treatment group showed a lower value (22.8% versus 47.2%, p = 0.0003) and greater improvement (53.4% versus 35.6%, p = 0.002). At follow-up, 70% of the treatment group had a normal caloric test result compared to only 34% of the control group. The mean hospital stay of the treatment group was significantly shorter than that of the control group (1.8 versus 3.0 d, p = 0.001). CONCLUSION: Glucocorticoids administered within 3 days after onset of vestibular neuronitis improves long-time recovery of vestibular function and reduces length of hospital stay.
OBJECTIVE: To report the effects of glucocorticoid treatment of acute vestibular neuronitis on recovery of vestibular function and length of hospital stay. STUDY DESIGN: Prospective, consecutive case series compared with historic controls. SETTING: Secondary referral academic hospital. PATIENTS: Patients with acute vestibular neuronitis. One group treated with glucocorticoids within 3 days after symptom onset (n = 33) and 2 historic untreated control groups (n = 41 and n = 67). INTERVENTIONS: Oral prednisolone 50 mg/d for 5 days with tapering of doses for the next 5 days, alternatively with intravenous betamethasone 8 mg on the first 1 to 2 days if nauseated. MAIN OUTCOME MEASURES: Extent of unilateral vestibular paresis (%) in the caloric test at presentation and at 12 months of follow-up. Length of hospital stay (days). RESULTS: The initial vestibular paresis value did not differ between the treatment group and the control group. At follow-up, the treatment group showed a lower value (22.8% versus 47.2%, p = 0.0003) and greater improvement (53.4% versus 35.6%, p = 0.002). At follow-up, 70% of the treatment group had a normal caloric test result compared to only 34% of the control group. The mean hospital stay of the treatment group was significantly shorter than that of the control group (1.8 versus 3.0 d, p = 0.001). CONCLUSION: Glucocorticoids administered within 3 days after onset of vestibular neuronitis improves long-time recovery of vestibular function and reduces length of hospital stay.
Authors: Sian Cousins; Nicholas J Cutfield; Diego Kaski; Antonella Palla; Barry M Seemungal; John F Golding; Jeffrey P Staab; Adolfo M Bronstein Journal: PLoS One Date: 2014-09-18 Impact factor: 3.240
Authors: A Greco; G F Macri; A Gallo; M Fusconi; A De Virgilio; G Pagliuca; C Marinelli; M de Vincentiis Journal: J Immunol Res Date: 2014-01-15 Impact factor: 4.818
Authors: R E Roberts; H Ahmad; M Patel; Danai Dima; R Ibitoye; M Sharif; R Leech; Q Arshad; A M Bronstein Journal: Neuroimage Clin Date: 2018-10-09 Impact factor: 4.881